Research Analysts’ Updated EPS Estimates for January, 22nd (ANDV, ARTC, BGNE, BHP, CBG, CSTE, ECL, ERJ, FBHS, FCCO)

Research Analysts’ updated eps estimates for Monday, January 22nd:

Andeavor (NYSE:ANDV) had its buy rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $153.00 target price on the stock.

Chardan Capital began coverage on shares of ArthroCare (NASDAQ:ARTC). The firm issued a buy rating on the stock.

Beigene (NASDAQ:BGNE) had its buy rating reiterated by analysts at Maxim Group. The analysts wrote, “BeiGene has announced pricing on a $750M public offering. The company intends to sell 7.4M ADS at a price of $101 per ADS, bringing the total share count to ~50M. After the underwriting discount, the company expects proceeds of ~$710M, bringing the estimated cash on the balance sheet to ~ $1B after including the portion of Celgene’s $263M upfront payment which was due in 4Q17 ($171M). Based on the 2017 burn rate of $260M (excluding nonrecurring collaboration revenue), the offering should extend BeiGene’s cash runway to the expected commercial launches of BGB-3111 and BGB- A317 in 2020. ○ Our model has been adjusted for the raise with several other factors being considered. After incorporating all these changes and rolling our metrics forward, our price target remains at $120. Recall that BGB-A317 is also being evaluated in pivotal trials in China for r/ r Hodgkin’s lymphoma and urothelial cancer, as well as a global P3 trial for NSCLC, bringing the number of ongoing pivotal trials to four. In addition, BeiGene has recently initiated a global PIII trial testing BGB-A317 (anti-PD-1 mAb tislelizumab) vs. Nexavar as a first-line treatment for advanced liver cancer. BGB-A317 is also in a global Phase III trial to treat non-small cell lung cancer (NSCLC), as well as two pivotal (China-based) trials to treat relapsed/ refractory Hodgkin’s lymphoma and urothelial cancer.””

BHP Billiton (NYSE:BHP) was downgraded by analysts at Sanford C. Bernstein from an outperform rating to a market perform rating.

Evercore ISI initiated coverage on shares of CBRE Group (NYSE:CBG). Evercore ISI issued a $48.00 target price on the stock.

Caesarstone (NASDAQ:CSTE) was downgraded by analysts at Credit Suisse Group AG from a neutral rating to an underperform rating. Credit Suisse Group AG currently has $21.00 target price on the stock, down from their previous target price of $28.00.

Boenning Scattergood started coverage on shares of Ecolab (NYSE:ECL). The firm issued an outperform rating on the stock.

Embraer (NYSE:ERJ) had its hold rating reiterated by analysts at Cowen Inc. Cowen Inc currently has a $28.00 target price on the stock.

Fortune Brands Home & Security (NYSE:FBHS) had its outperform rating reissued by analysts at Credit Suisse Group AG. The firm currently has a $80.00 price target on the stock, up from their previous price target of $74.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

First Community (NASDAQ:FCCO) was downgraded by analysts at FIG Partners from an outperform rating to a market perform rating.

Freeport-McMoRan (NYSE:FCX) had its neutral rating reiterated by analysts at CIBC.

First Republic Bank (NYSE:FRC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Shares of First Republic have underperformed the industry over the last six months. Also, its earnings surprise history is not impressive. The bank missed the Zacks Consensus Estimate in three of the trailing four quarters. The company’s fourth-quarter 2017 results disappointed on rising costs and provisions. Despite rising rates, net interest margin also declined. However, a considerable rise in loans and deposit balances were recorded aiding high revenues. Though the company remains well positioned for growth, given its simpler business model and non-engagement in additional businesses, escalating costs owing to investments in digital initiatives are expected to hurt the bank’s bottom-line growth further. Additionally, First Republic’s stretched valuation indicates limited upside potential for the stock.”

GTT Communications (NYSE:GTT) had its buy rating reiterated by analysts at Craig Hallum. They currently have a $50.00 price target on the stock, up from their previous price target of $40.00.

Honeywell International (NYSE:HON) had its buy rating reaffirmed by analysts at Cowen Inc. They currently have a $168.00 target price on the stock.

Harris (NYSE:HRS) had its buy rating reiterated by analysts at Cowen Inc. Cowen Inc currently has a $157.00 target price on the stock.

Installed Building Products (NYSE:IBP) had its outperform rating reaffirmed by analysts at Credit Suisse Group AG. They currently have a $85.00 target price on the stock, up from their previous target price of $73.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Intercept Pharmaceuticals (NASDAQ:ICPT) had its outperform rating reiterated by analysts at Credit Suisse Group AG. The firm currently has a $167.00 target price on the stock, down from their previous target price of $201.00.

First Internet Bancorp (NASDAQ:INBK) was downgraded by analysts at FIG Partners from an outperform rating to a market perform rating.

Chardan Capital initiated coverage on shares of Iovance Biotherapeutics (NASDAQ:IOVA). They issued a buy rating on the stock.

Jeld-Wen (NYSE:JELD) had its outperform rating reiterated by analysts at Credit Suisse Group AG. The firm currently has a $47.00 price target on the stock, up from their previous price target of $41.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Philips Lighting (AMS:LIGHT) had its buy rating reaffirmed by analysts at Goldman Sachs Group Inc.

Masco (NYSE:MAS) had its neutral rating reissued by analysts at Credit Suisse Group AG. Credit Suisse Group AG currently has a $46.00 target price on the stock, up from their previous target price of $36.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Citigroup Inc started coverage on shares of The Medicines (NASDAQ:MDCO). Citigroup Inc issued a buy rating on the stock.

Mohawk Industries (NYSE:MHK) had its outperform rating reaffirmed by analysts at Credit Suisse Group AG. Credit Suisse Group AG currently has a $310.00 target price on the stock, up from their previous target price of $303.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

MarketAxess (NASDAQ:MKTX) had its market perform rating reissued by analysts at Raymond James Financial, Inc..

Monster Beverage (NASDAQ:MNST) had its buy rating reiterated by analysts at Cowen Inc. The firm currently has a $77.00 price target on the stock.

Moog (NYSE:MOG.A) had its hold rating reiterated by analysts at Cowen Inc. The firm currently has a $97.00 price target on the stock.

Obalon Therapeutics (NASDAQ:OBLN) had its buy rating reaffirmed by analysts at Canaccord Genuity. Canaccord Genuity currently has a $11.00 target price on the stock, down from their previous target price of $15.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Owens Corning (NYSE:OC) had its outperform rating reaffirmed by analysts at Credit Suisse Group AG. The firm currently has a $110.00 target price on the stock, up from their previous target price of $95.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

FBN Securities assumed coverage on shares of Okta (NASDAQ:OKTA). The firm issued an outperform rating on the stock.

Orbotech (NASDAQ:ORBK) had its buy rating reissued by analysts at Lake Street Capital. They currently have a $62.00 price target on the stock.

Oxford Immunotec Global (NASDAQ:OXFD) had its buy rating reaffirmed by analysts at Cowen Inc. The firm currently has a $15.00 target price on the stock.

Phillips 66 (NYSE:PSX) had its buy rating reiterated by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $115.00 price target on the stock.

Qiagen (NASDAQ:QGEN) had its buy rating reaffirmed by analysts at Deutsche Bank AG.

SAP (NYSE:SAP) had its neutral rating reiterated by analysts at Royal Bank of Canada.

Starbucks (NASDAQ:SBUX) had its outperform rating reiterated by analysts at Wedbush. They currently have a $60.00 target price on the stock, down from their previous target price of $70.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Schlumberger (NYSE:SLB) had its buy rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a $95.00 price target on the stock, up from their previous price target of $85.00.

Spirit AeroSystems (NYSE:SPR) had its buy rating reaffirmed by analysts at Cowen Inc. The firm currently has a $110.00 target price on the stock.

Royal Bank of Canada began coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT). Royal Bank of Canada issued an outperform rating on the stock.

Symantec (NASDAQ:SYMC) was downgraded by analysts at Credit Suisse Group AG from an outperform rating to a neutral rating.

USG (NYSE:USG) had its underperform rating reaffirmed by analysts at Credit Suisse Group AG. The firm currently has a $36.00 target price on the stock, up from their previous target price of $26.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Valero Energy (NYSE:VLO) had its hold rating reiterated by analysts at Piper Jaffray Companies. They currently have a $98.00 price target on the stock.

Morgan Stanley assumed coverage on shares of Worldpay (NYSE:WP). The firm issued an overweight rating on the stock.

Receive News & Ratings for Andeavor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andeavor and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply